Through its ubiquitinase activity and RNA binding ability, TRIM56 has been widely shown to directly target viral components to inhibit infection of several RNA viruses via its RING and C-terminal structural domains (Fu et al, 2023). The gene discussed is TRIM56; the disease is infection.